Matthew Adamow

5.4k citations
12 papers · 525 indexed · 1 hit paper · h-index 7
Topics
Cancer Immunotherapy and Biomarkers (8 papers)CAR-T cell therapy research (4 papers)Immunotherapy and Immune Responses (4 papers)
Partner nations
United StatesGreeceHaiti

In The Last Decade

Matthew Adamow

12 papers receiving 510 citations

Hit Papers

Integrated NY-ESO-1 antibody and CD8+T-cell responses cor...2011202620162021201150100150200250

Peers

Matthew Adamow
Comparison fields: 5 of 54
  • Immunology 398
  • Oncology 350
  • Molecular Biology 127
  • Infectious Diseases 31
  • Pulmonary and Respiratory Medicine 31
Replace Baukje‐Nynke Hoogeboom with:
Baukje‐Nynke Hoogeboom Netherlands
Nikki M. Loof Netherlands
Korina G. Veenstra United States
Hiep Khong United States
Mara Valentini Italy
Pepijn G.J.T.B. Wijnands Netherlands
Kenzo Ohara Japan
Özcan Met Denmark
Carmen Stecher Austria
Miao-La Ke China
Matthew Adamow relative to Baukje‐Nynke Hoogeboom Netherlands Baukje‐Nynke Hoogeboom's profile →
Citations per field
00.5×1.5×2.1×
Baukje‐Nynke Hoogeboom · 1×
Citations per year

Countries citing papers authored by Matthew Adamow

Since Specialization
Citations

This map shows the geographic impact of Matthew Adamow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Adamow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Adamow more than expected).

Fields of papers citing papers by Matthew Adamow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Adamow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Adamow. The network helps show where Matthew Adamow may publish in the future.

Co-authorship network of co-authors of Matthew Adamow

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Adamow. A scholar is included among the top collaborators of Matthew Adamow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Adamow. Matthew Adamow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 4
2 4
3 1
4 3
5 6
6 50
7 2
8 111
9 38
10 13
11
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumabbreakdown →
254
12 39

About Matthew Adamow

Matthew Adamow is a scholar working on Immunology, Oncology and Cancer Research, having authored 12 papers that have together received 525 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (398 citations), Oncology (350 citations) and Biotechnology (26 citations). Matthew Adamow has collaborated with scholars based in United States, Greece and Haiti. Frequent co-authors include Katherine S. Panageas, Jianda Yuan, Jedd D. Wolchok, Teresa Rasalan, Deborah Kuk, Humilidad F. Gallardo, Brian Ginsberg, Stephanie Terzulli, Sacha Gnjatic and Ruth Halaban. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026